Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 EMA Priority Medicines scheme (PRIME): will more paying-for-performance agreements be needed due to immature data?

× No keyword cloud information.

3 in total

1. Cancer Drugs Approved on the Basis of a Surrogate End Point and Subsequent Overall Survival: An Analysis of 5 Years of US Food and Drug Administration Approvals.

Authors: Chul Kim; Vinay Prasad
Journal: JAMA Intern Med Date: 2015-12 Impact factor: 21.873

2. Pharmaceutical patents, R&D incentives and access to new drugs: new ways of progress at the crossroad.

Authors: Fernando Antoñanzas; Carmelo Juárez-Castelló; Roberto Rodríguez-Ibeas
Journal: Eur J Health Econ Date: 2011-10

Review 3. Should the patent system for pharmaceuticals be replaced? A theoretical approach.

Authors: Fernando Antoñanzas; Roberto Rodríguez-Ibeas; Carmelo A Juárez-Castelló
Journal: Expert Rev Pharmacoecon Outcomes Res Date: 2014-06-17 Impact factor: 2.217

3 in total

1 in total

1. [Regulations on expanded access and compassionate use of medicines in South AmericaRegulación de los programas de acceso ampliado y uso compasivo de medicamentos en América del Sur].

Authors: Gabriela Bittencourt Gonzalez Mosegui; Fernando Antoñanzas
Journal: Rev Panam Salud Publica Date: 2019-07-08

1 in total